CEP131 overexpression promotes cell proliferation and migration in hepatocellular carcinoma through activating the phosphatidylinositol-3 kinase (PI3K)/AKT signaling pathway, therefore, CEP131 is an oncogene and a candidate prognostic marker in the disease (Liu et al., 2017). Here, AKT1 is linked to hepatocellular carcinoma.